Tel Aviv - Delayed Quote ILA
Lineage Cell Therapeutics, Inc. (LCTX.TA)
169.10
+10.50
+(6.62%)
At close: 5:24:34 PM GMT+3
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
113,218
101,019
123,664
174,545
Total Liabilities Net Minority Interest
36,206
38,996
51,728
83,647
Total Equity Gross Minority Interest
77,012
62,023
71,936
90,898
Total Capitalization
78,381
63,419
73,339
92,221
Common Stock Equity
78,381
63,419
73,339
92,221
Capital Lease Obligations
2,514
2,952
3,896
2,802
Net Tangible Assets
21,169
6,185
15,975
34,727
Working Capital
37,020
20,481
41,019
64,433
Invested Capital
78,381
63,419
73,339
92,221
Tangible Book Value
21,169
6,185
15,975
34,727
Total Debt
2,514
2,952
3,896
2,802
Share Issued
220,416.33
174,986.67
170,093
169,477
Ordinary Shares Number
220,416.33
174,986.67
170,093
169,477
12/31/2021 - 9/8/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEN.TA Compugen Ltd.
515.40
-3.95%
ENLV.TA Enlivex Therapeutics Ltd.
337.50
+2.09%
BLRX.TA BioLineRx Ltd.
1.8000
+5.88%
EVGN.TA Evogene Ltd.
389.00
-7.49%
NERV Minerva Neurosciences, Inc.
1.7500
-1.13%
CGEN Compugen Ltd.
1.4800
+2.78%
PPBT Purple Biotech Ltd
2.7300
+1.11%
BLRX BioLineRx Ltd.
3.0021
+0.07%
CLDX Celldex Therapeutics, Inc.
19.58
+0.77%
EVGN Evogene Ltd.
1.1100
+1.83%